Oxygenta Pharmaceutical share news and announcements
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹47.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,726
Oxygenta Pharmaceutical share news and announcements
489 announcements, routine notices left out, newest first. Page 4 of 10.
Nov 2023
Oct 2023
Sep 2023
4 Sep · Board meeting
Aug 2023
7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
Jul 2023
13 Jul · Post Offer Advertisement
Jun 2023
15 Jun · Offer Opening Public Announcement
May 2023
24 May · Board meeting
Meeting on 30 May 2023: audited results4 May · Compliance Certificate For The Year Ended 31-03-2023
3 May · Announcement under Regulation 30 (LODR)-Allotment
Apr 2023
29 Apr · Announcement under Regulation 30 (LODR)-Allotment
28 Apr · Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015.
26 Apr · Announcement under Regulation 30 (LODR)-Allotment
Mar 2023
6 Mar · Detailed Public Statement
Feb 2023
27 Feb · Announcement under Regulation 30 (LODR)-Issue of Securities
22 Feb · Board meeting
Meeting on 27 Feb 2023: increase in authorised capital and preferential issue of shares22 Feb · Intimation Of BSE Decision On Re-Classification Of Outgoing Promoter(S) From Promoter Category To Public Category
21 Feb · Disclosure Under Regulation 31A Of Securities And Exchange Board Of India (LODR) Regulations, 2015.
21 Feb · Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (LODR) Regulations, 2015.
8 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Jan 2023